In the last 12 months, insiders at CNS Pharmaceuticals, Inc. ($CNSP) filed 39 transactions with the SEC: 4 open-market purchases totaling $89,999 and 0 sales totaling $0. Net insider sentiment: net buying.
CNS Pharmaceuticals, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Climaco John M (Chief Executive Officer) — 6 transactions totaling $50,000
- Downs Christopher (Chief Financial Officer) — 6 transactions totaling $20,000
- Evans Carl Anthony (Director) — 5 transactions totaling $10,000
- Gumulka Jerzy (Director) — 6 transactions totaling $10,000
- Keyes Jeffry R. (Director) — 3 transactions totaling $0
View all SEC Filings for CNS Pharmaceuticals, Inc. (CNSP).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 2, 2026 | O'Loughlin Steve | Chief Financial Officer | A | Restricted Stock Units | 9500 | $0.00 | 9,500.0000 | 620,290 | 9999.99% | 1.53% |
| March 2, 2026 | Faulkner Eric | Chief Technology Officer | A | Restricted Stock Units | 9500 | $0.00 | 9,500.0000 | 620,290 | 9999.99% | 1.53% |
| Jan. 1, 2026 | Levin Rami | CEO and President | A | Restricted Stock Units | 19000 | $0.00 | 19,000.0000 | 620,290 | 9999.99% | 3.06% |
| Nov. 17, 2025 | Keyes Jeffry R. | Director | A | Option to purchase common stock | 1517 | $0.00 | 1,517.0000 | 620,290 | 9999.99% | 0.24% |
| Nov. 17, 2025 | Gumulka Jerzy | Director | A | Option to purchase common stock | 1517 | $0.00 | 1,517.0000 | 620,290 | 9999.99% | 0.24% |
| Nov. 17, 2025 | Downs Christopher | Chief Financial Officer | A | Option to purchase common stock | 4881 | $0.00 | 4,881.0000 | 620,290 | 9999.99% | 0.79% |
| Nov. 17, 2025 | Charles Faith L. | Director | A | Option to purchase common stock | 1517 | $0.00 | 1,517.0000 | 620,290 | 9999.99% | 0.24% |
| Nov. 17, 2025 | Mahery Amy | Director | A | Option to purchase common stock | 1517 | $0.00 | 1,517.0000 | 620,290 | 9999.99% | 0.24% |
| Nov. 17, 2025 | Climaco John M | Chief Executive Officer | A | Option to purchase common stock | 9761 | $0.00 | 9,761.0000 | 620,290 | 9999.99% | 1.57% |
| Nov. 17, 2025 | Cockroft Bettina M. | Director | A | Option to purchase common stock | 1517 | $0.00 | 1,517.0000 | 620,290 | 9999.99% | 0.24% |
| April 8, 2024 | Cockroft Bettina M. | Director | A | Option to purchase common stock | 17500 | $0.00 | 35,574.0000 | 0 | 96.82% | 0.00% |
| April 8, 2024 | Cockroft Bettina M. | Director | A | Restricted Stock Units | 17500 | $0.00 | 53,074.0000 | 0 | 49.19% | 0.00% |
| April 8, 2024 | Climaco John M | Chief Executive Officer | A | Option to purchase common stock | 83000 | $0.00 | 476,533.0000 | 0 | 21.09% | 0.00% |
| April 8, 2024 | Climaco John M | Chief Executive Officer | A | Restricted Stock Units | 83000 | $0.00 | 559,533.0000 | 0 | 17.42% | 0.00% |
| April 8, 2024 | Charles Faith L. | Director | A | Option to purchase common stock | 17500 | $0.00 | 47,315.0000 | 0 | 58.70% | 0.00% |
| April 8, 2024 | Charles Faith L. | Director | A | Restricted Stock Units | 17500 | $0.00 | 64,815.0000 | 0 | 36.99% | 0.00% |
| April 8, 2024 | Mahery Amy | Director | A | Option to purchase common stock | 17500 | $0.00 | 29,920.0000 | 0 | 140.90% | 0.00% |
| April 8, 2024 | Mahery Amy | Director | A | Restricted Stock Units | 17500 | $0.00 | 47,420.0000 | 0 | 58.49% | 0.00% |
| April 8, 2024 | Keyes Jeffry R. | Director | A | Option to purchase common stock | 17500 | $0.00 | 62,928.0000 | 0 | 38.52% | 0.00% |
| April 8, 2024 | Keyes Jeffry R. | Director | A | Restricted Stock Units | 17500 | $0.00 | 80,428.0000 | 0 | 27.81% | 0.00% |
| April 8, 2024 | Gumulka Jerzy | Director | A | Option to purchase common stock | 17500 | $0.00 | 129,594.0000 | 0 | 15.61% | 0.00% |
| April 8, 2024 | Gumulka Jerzy | Director | A | Restricted Stock Units | 17500 | $0.00 | 147,594.0000 | 0 | 13.45% | 0.00% |
| April 8, 2024 | Evans Carl Anthony | Director | A | Option to purchase common stock | 17500 | $0.00 | 129,594.0000 | 0 | 15.61% | 0.00% |
| April 8, 2024 | Evans Carl Anthony | Director | A | Restricted Stock Units | 17500 | $0.00 | 147,094.0000 | 0 | 13.50% | 0.00% |
| April 8, 2024 | Downs Christopher | Chief Financial Officer | A | Option to purchase common stock | 40000 | $0.00 | 201.5720 | 0 | 0.00% | 0.00% |
| April 8, 2024 | Downs Christopher | Chief Financial Officer | A | Restricted Stock Units | 40000 | $0.00 | 241.5720 | 0 | 0.00% | 0.00% |
| Feb. 1, 2024 | Climaco John M | Chief Executive Officer | P | Common stock | 166666 | $0.30 | 215,676.0000 | 0 | 340.07% | 0.00% |
| Feb. 1, 2024 | Climaco John M | Chief Executive Officer | A | Series A Warrant to purchase common stock | 166666 | $0.00 | 226,867.0000 | 0 | 276.85% | 0.00% |
| Feb. 1, 2024 | Climaco John M | Chief Executive Officer | A | Series B Warrant to purchase common stock | 166666 | $0.00 | 393,533.0000 | 0 | 73.46% | 0.00% |
| Feb. 1, 2024 | Downs Christopher | Chief Financial Officer | A | Series B Warrant to purchase common stock | 66666 | $0.00 | 161,572.0000 | 0 | 70.24% | 0.00% |
| Feb. 1, 2024 | Downs Christopher | Chief Financial Officer | A | Series A Warrant to purchase common stock | 66666 | $0.00 | 94,906.0000 | 0 | 236.07% | 0.00% |
| Feb. 1, 2024 | Downs Christopher | Chief Financial Officer | P | Common stock | 66666 | $0.30 | 103,438.0000 | 0 | 181.30% | 0.00% |
| Feb. 1, 2024 | Evans Carl Anthony | Director | A | Series B Warrant to purchase common stock | 33333 | $0.00 | 112,094.0000 | 0 | 42.32% | 0.00% |
| Feb. 1, 2024 | Evans Carl Anthony | Director | A | Series A Warrant to purchase common stock | 33333 | $0.00 | 78,761.0000 | 0 | 73.38% | 0.00% |
| Feb. 1, 2024 | Evans Carl Anthony | Director | P | Common stock | 33333 | $0.30 | 33,458.0000 | 0 | 9999.99% | 0.00% |
| Feb. 1, 2024 | Gumulka Jerzy | Director | A | Series B Warrant to purchase common stock | 33333 | $0.00 | 112,094.0000 | 0 | 42.32% | 0.00% |
| Feb. 1, 2024 | Gumulka Jerzy | Director | A | Series A Warrant to purchase common stock | 33333 | $0.00 | 78,761.0000 | 0 | 73.38% | 0.00% |
| Feb. 1, 2024 | Gumulka Jerzy | Director | P | Common stock | 33333 | $0.30 | 43,006.0000 | 0 | 344.60% | 0.00% |
| Feb. 1, 2024 | Mahery Amy | Director | A | Option to purchase common stock | 12420 | $0.00 | 12,420.0000 | 0 | 9999.99% | 0.00% |